Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 99, 2015
Previous Article Next Article

Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Author affiliations

Abstract

We describe here a drug depot hydrogel system comprising sildenafil (SIL; commercially available as Viagra®) incorporated in mesoporous silica nanoparticles (MSNs; around 60 nm of diameter) and conjugated with a thermosensitive poloxamer (Pluronic F-127 or PF127; possessing a liquid–gel transition over a determined temperature). The conjugation of these components results in an anticancer biomaterial with optimized physico-chemical properties: (i) MSNs are colloidally stabilized mainly through repulsive depletion forces manifested in PF127 concentrations above 5 wt%; (ii) the gelation temperature of the systems is set to about 20 °C (attained with 18 wt% of PF127) in order to result in prompt gelation when they are intraperitoneally administered (in rats) as liquids; (iii) and the hydrogel is able to induce a prolonged release of MSNs + SIL. After testing these new formulations against chemically induced prostate cancer in rats, the histopathological analyses of the prostate showed that the hybrid systems were able to largely reduce the prostate tumor level, and also highlighted the role of the MSNs in this process, since the improvement of the tumor condition was proportional to the nanoparticles concentration.

Graphical abstract: Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Jul 2015, accepted on 17 Sep 2015 and first published on 17 Sep 2015


Article type: Paper
DOI: 10.1039/C5RA15006J
Citation: RSC Adv., 2015,5, 81348-81355

  •   Request permissions

    Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

    C. P. Silveira, L. M. Apolinário, W. J. Fávaro, A. J. Paula and N. Durán, RSC Adv., 2015, 5, 81348
    DOI: 10.1039/C5RA15006J

Search articles by author

Spotlight

Advertisements